← All trials
NCT04014283
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2014
- Primary completion
- Jun 30, 2024
- Completion date
- Sep 30, 2024
- First posted
- —
- Last posted
- —
- Enrollment
- 7000
- Arms / groups
- 5 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Read-Gene S.A.Lead sponsor
- Government of PolandCollaborator
- West Pomeranian University of TechnologyCollaborator
- Vipharm S.A.Collaborator
- Read-Gene S.A.Study chair
- Read-Gene S.A.Overall official - principal investigator
- Read-Gene S.A.Reponsible party - principal investigator
- IQ Pharma S.A.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.